HUANG Jun, JIANG Jingjing, BAO Yunli, LI Na, ZHENG Ying, ZHENG Xiaofeng, YU Xiaohui, ZHANG Jiucong. Research progress on the immunosuppressive mechanism of co-inhibitory receptor T cell immunoglobulin and immunoglobulin and tyrosine-based inhibitory motif domain[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 135-138. DOI: 10.7619/jcmp.20232354
Citation: HUANG Jun, JIANG Jingjing, BAO Yunli, LI Na, ZHENG Ying, ZHENG Xiaofeng, YU Xiaohui, ZHANG Jiucong. Research progress on the immunosuppressive mechanism of co-inhibitory receptor T cell immunoglobulin and immunoglobulin and tyrosine-based inhibitory motif domain[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 135-138. DOI: 10.7619/jcmp.20232354

Research progress on the immunosuppressive mechanism of co-inhibitory receptor T cell immunoglobulin and immunoglobulin and tyrosine-based inhibitory motif domain

  • The occurrence and development of malignant tumors are closely related to immune checkpoint receptors, and tumor cells can evade immune surveillance by activating the immune checkpoint pathway. T cell immunoglobulin and ITIM domain(TIGIT) is an inhibitory receptor expressed on lymphocytes, which can inhibit the function of natural killer cells(NK) and T cells through a variety of mechanisms, making tumor cells escape from the surveillance of the immune system. This article made a systematic review on the research progress of the immunosuppressive mechanism of TIGIT, and reviewed the research progress of the immunosuppressive mechanism of TIGIT.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return